Policy & Medicine - Legal, Regulatory, and Compliance Issues

By Rick Daigle \FDA Leaders Illuminate Regulatory Path Forward at Dermatology Meeting in San Diego At the bustling American…

In early 2024, the U.S. healthcare sector experienced a significant cybersecurity crisis when Change Healthcare, a vital…

The Brookings Institution recently published a study on the outcomes under the No Surprises Act arbitration process, finding that…

Colorado’s General Assembly passed a law in 2019 that allowed the Colorado Department of Health Care Policy and Financing (HCPF)…

The United States Court of Appeals for the Second Circuit recently held that to act “willfully” under the federal Anti-Kickback…

The United States District Court for the District of Delaware recently rejected AstraZeneca’s lawsuit challenging the authority…

Earlier this year, the Alliance for Connected Care, the American Telemedicine Association, ATA Action, the Consumer Technology…

The Department of Health and Human Services (HHS) Office of Inspector General (OIG) recently issued Advisory Opinion No. 24-02,…

In an initiative to establish a more ethical, equitable, and collaborative healthcare system in the United States, leading…

Health Affairs recently published a study that found Medicare Part D plans greatly increased utilization restrictions on…